TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Portable Mantram Meditation for Veterans With Military Related PTSD
Brief Summary: The aim of this study was to determine the usefulness of a portable, meditation-based intervention called the Mantram Repetition Program (MRP) for Veterans with military-related posttraumatic stress disorder (PTSD). This study compared the individual delivery of the MRP to individual delivery of Present-Centered Therapy (PCT) at two sites in San Diego, California, and Bedford, Massachusetts.


Options:
A: Arm Label: Arm 1: Mindfulness-Based Stress Reduction (MBSR); Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Based Stress Reduction (MBSR) | Arm Label: Arm 2: Present-Centered Group Therapy (PCGT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present-Centered Group Therapy (PCGT) | Intervention Type: BEHAVIORAL; Name: Mindfulness-Based Stress Reduction (MBSR); Assigned to Arm(s): Arm 1: Mindfulness-Based Stress Reduction (MBSR) | Intervention Type: BEHAVIORAL; Name: Present-Centered Group Therapy (PCGT); Assigned to Arm(s): Arm 2: Present-Centered Group Therapy (PCGT)
B: Arm Label: Minimal Contact Control; Type: OTHER; Interventions: Behavioral: Minimal Contact Control | Arm Label: PE-Massed; Type: EXPERIMENTAL; Interventions: Behavioral: Prolonged Exposure Therapy - Massed | Arm Label: PE-Spaced; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prolonged Exposure Therapy - Spaced | Arm Label: Present-Centered Therapy (PCT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present-Centered Therapy | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure Therapy - Massed; Assigned to Arm(s): PE-Massed | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure Therapy - Spaced; Assigned to Arm(s): PE-Spaced | Intervention Type: BEHAVIORAL; Name: Minimal Contact Control; Assigned to Arm(s): Minimal Contact Control | Intervention Type: BEHAVIORAL; Name: Present-Centered Therapy; Assigned to Arm(s): Present-Centered Therapy (PCT)
C: Arm Label: Mantram Repetition Program (MRP); Type: EXPERIMENTAL; Interventions: Behavioral: Mantram Repetition Program (MRP) | Arm Label: Present Centered Therapy (PCT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present Centered Therapy (PCT) | Intervention Type: BEHAVIORAL; Name: Mantram Repetition Program (MRP); Assigned to Arm(s): Mantram Repetition Program (MRP) | Intervention Type: BEHAVIORAL; Name: Present Centered Therapy (PCT); Assigned to Arm(s): Present Centered Therapy (PCT)
D: Arm Label: Group Cognitive Processing Therapy-Cognitive Only; Type: EXPERIMENTAL; Interventions: Behavioral: Group Cognitive Processing Therapy-Cognitive Only | Arm Label: Group Present Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Present Centered Therapy | Intervention Type: BEHAVIORAL; Name: Group Cognitive Processing Therapy-Cognitive Only; Assigned to Arm(s): Group Cognitive Processing Therapy-Cognitive Only | Intervention Type: BEHAVIORAL; Name: Group Present Centered Therapy; Assigned to Arm(s): Group Present Centered Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Foley Catheter Plus Vaginal Isosorbide Mononitrate Versus Vaginal Misoprostol for Induction of Labour:a Randomised Controlled Trial
Brief Summary: The use of foley catheter was tested many times and proved to be effective for induction of labour.


Options:
A: Arm Label: FOLEY BALLOON; Type: ACTIVE_COMPARATOR; Interventions: Device: FOLEY BALLOON | Arm Label: CERVIDIL; Type: ACTIVE_COMPARATOR; Interventions: Drug: CERVIDIL (Dinoprostone) | Intervention Type: DRUG; Name: CERVIDIL (Dinoprostone); Assigned to Arm(s): CERVIDIL | Intervention Type: DEVICE; Name: FOLEY BALLOON; Assigned to Arm(s): FOLEY BALLOON
B: Arm Label: Combined approach: Foley Balloon + Vaginal Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley Balloon + Vaginal Misoprostol | Arm Label: Single approach: Vaginal Misoprostol only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vaginal Misoprostol | Intervention Type: DRUG; Name: Vaginal Misoprostol; Assigned to Arm(s): Single approach: Vaginal Misoprostol only | Intervention Type: DEVICE; Name: Foley Balloon + Vaginal Misoprostol; Assigned to Arm(s): Combined approach: Foley Balloon + Vaginal Misoprostol
C: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Foley Catheter and Oxytocin; Type: EXPERIMENTAL; Interventions: Device: Foley Catheter, Drug: Oxytocin | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter and Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Foley Catheter and Oxytocin, Oxytocin
D: Arm Label: folye catheter plus vaginal IMN; Type: EXPERIMENTAL; Interventions: Device: foley catheter, Drug: Vaginal IMN | Arm Label: Misoprostol vaginally; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DEVICE; Name: foley catheter; Assigned to Arm(s): folye catheter plus vaginal IMN | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol vaginally | Intervention Type: DRUG; Name: Vaginal IMN; Assigned to Arm(s): folye catheter plus vaginal IMN

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Foley Catheter Plus Vaginal Isosorbide Mononitrate Versus Vaginal Misoprostol for Induction of Labour:a Randomised Controlled Trial
Brief Summary: The use of foley catheter was tested many times and proved to be effective for induction of labour.


Options:
A: Arm Label: Mechanical cervical ripening; Type: EXPERIMENTAL; Interventions: Device: Mechanical cervical ripening | Arm Label: Pharmacological cervical ripening; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pharmacological cervical ripening | Intervention Type: DEVICE; Name: Mechanical cervical ripening; Assigned to Arm(s): Mechanical cervical ripening | Intervention Type: DRUG; Name: Pharmacological cervical ripening; Assigned to Arm(s): Pharmacological cervical ripening
B: Arm Label: folye catheter plus vaginal IMN; Type: EXPERIMENTAL; Interventions: Device: foley catheter, Drug: Vaginal IMN | Arm Label: Misoprostol vaginally; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DEVICE; Name: foley catheter; Assigned to Arm(s): folye catheter plus vaginal IMN | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol vaginally | Intervention Type: DRUG; Name: Vaginal IMN; Assigned to Arm(s): folye catheter plus vaginal IMN
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Induction of labor with foley balloon with 30cc | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon - 60cc of saline; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon with 30cc; Assigned to Arm(s): 2
D: Arm Label: Cook Cervical balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: Cook cervical balloon | Arm Label: Prostin E2 Vaginal suppository; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prostin E2 Vaginal Suppository | Intervention Type: DEVICE; Name: Cook cervical balloon; Assigned to Arm(s): Cook Cervical balloon | Intervention Type: DRUG; Name: Prostin E2 Vaginal Suppository; Assigned to Arm(s): Prostin E2 Vaginal suppository

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Brief Summary: What is the effect of early high frequency oscillation (HFO) versus a lung-protective conventional ventilation (CV) strategy (using HFO only as rescue therapy), on all-cause hospital mortality among patients with severe early acute respiratory distress syndrome (ARDS)?


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: prone position | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone position; Assigned to Arm(s): A
B: Arm Label: HFO-TGI; Type: EXPERIMENTAL; Interventions: Other: High Frequency Oscillation and Tracheal Gas Insufflation | Arm Label: CMV; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: High Frequency Oscillation and Tracheal Gas Insufflation; Assigned to Arm(s): HFO-TGI
C: Arm Label: Conventional Ventilation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Lung Protective Ventilation | Arm Label: High Frequency Oscillation; Type: EXPERIMENTAL; Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator | Intervention Type: DEVICE; Name: SensorMedics 3100B High Frequency Oscillatory Ventilator; Assigned to Arm(s): High Frequency Oscillation | Intervention Type: PROCEDURE; Name: Lung Protective Ventilation; Assigned to Arm(s): Conventional Ventilation
D: Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: High-frequency Oscillation and Tracheal Gas Insufflation | Intervention Type: OTHER; Name: High-frequency Oscillation and Tracheal Gas Insufflation; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Brief Summary: What is the effect of early high frequency oscillation (HFO) versus a lung-protective conventional ventilation (CV) strategy (using HFO only as rescue therapy), on all-cause hospital mortality among patients with severe early acute respiratory distress syndrome (ARDS)?


Options:
A: Arm Label: Focal ARDS; Type: EXPERIMENTAL; Interventions: Procedure: Mechanical ventilation | Arm Label: non focal ARDS; Type: OTHER; Interventions: Procedure: Mechanical ventilation | Intervention Type: PROCEDURE; Name: Mechanical ventilation; Assigned to Arm(s): Focal ARDS, non focal ARDS
B: Intervention Type: DRUG; Name: Mythylprednisolone; Assigned to Arm(s): N/A
C: Arm Label: prone position; Type: ACTIVE_COMPARATOR; Interventions: Procedure: prone positioning | Arm Label: supine position; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone positioning; Assigned to Arm(s): prone position
D: Arm Label: Conventional Ventilation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Lung Protective Ventilation | Arm Label: High Frequency Oscillation; Type: EXPERIMENTAL; Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator | Intervention Type: DEVICE; Name: SensorMedics 3100B High Frequency Oscillatory Ventilator; Assigned to Arm(s): High Frequency Oscillation | Intervention Type: PROCEDURE; Name: Lung Protective Ventilation; Assigned to Arm(s): Conventional Ventilation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exploratory Study of Different Doses of Endurance Exercise in People With Parkinson Disease
Brief Summary: The purpose of this study is to learn more about the effects of exercise on patients who have been recently diagnosed with Parkinson's disease (PD). The investigators are going to test two levels of exercise (moderate to vigorous) against no exercise. The investigators think that exercise may reduce the symptoms the of PD, and the investigators hope to learn what level of exercise will offer the most benefit.


Options:
A: Arm Label: ActiveStep; Type: ACTIVE_COMPARATOR; Interventions: Device: ActiveStep Treadmill | Arm Label: Standard physical therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Physical Therapy | Intervention Type: DEVICE; Name: ActiveStep Treadmill; Assigned to Arm(s): ActiveStep | Intervention Type: OTHER; Name: Physical Therapy; Assigned to Arm(s): Standard physical therapy
B: Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Behavioral: No Intervention | Arm Label: Vigorous Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Vigorous Exercise | Arm Label: Moderate Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Moderate Exercise | Intervention Type: BEHAVIORAL; Name: Moderate Exercise; Assigned to Arm(s): Moderate Exercise | Intervention Type: BEHAVIORAL; Name: Vigorous Exercise; Assigned to Arm(s): Vigorous Exercise | Intervention Type: BEHAVIORAL; Name: No Intervention; Assigned to Arm(s): Control Group
C: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Device: Gait Trainer 3 | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Gait Trainer 3 | Intervention Type: DEVICE; Name: Gait Trainer 3; Assigned to Arm(s): Control Group, Experimental group
D: Arm Label: Droxidopa; Type: EXPERIMENTAL; Interventions: Drug: Droxidopa | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Droxidopa; Assigned to Arm(s): Droxidopa | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Vitamin D Supplementation During Lactation on Vitamin D Status, Bone Mineralisation and Body Composition of Mother and Their Exclusively Breastfed Infants.
Brief Summary: The investigators would like to test the hypothesis that maternal vitamin D supplementation during lactation in dose 1200IU/d (400IU from multivitamins + 800 IU cholecalciferol) is more effective than 400IU/d (400IU from multivitamins + placebo)to built appropriate maternal vitamin D status and could be beneficial for maternal and infants bone mineralization and body composition (proper proportion of muscle and fat tissues in body weight) and is safe for both.

The investigators also want to confirm that vitamin D supplementation of exclusively breastfed infants in dose 400IU/d is adequate to build appropriate vitamin D status independently of mother's vitamin D supplementation up to 1200 ID/d.

Additionally the investigators hypothesize that because of changes in lifestyle there will be no substantial seasonal differences in vitamin D status of pregnant women at the delivery and their newborn infants.


Options:
A: Arm Label: High-dose vitamin D; Type: EXPERIMENTAL; Interventions: Drug: High-dose vitamin D 3 | Arm Label: Conventional-dose vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Conventional-Dose Vitamin D 3 | Intervention Type: DRUG; Name: High-dose vitamin D 3; Assigned to Arm(s): High-dose vitamin D | Intervention Type: DRUG; Name: Conventional-Dose Vitamin D 3; Assigned to Arm(s): Conventional-dose vitamin D
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: n-3 fatty acid | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: olive oil | Intervention Type: DIETARY_SUPPLEMENT; Name: n-3 fatty acid; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil; Assigned to Arm(s): 2
C: Arm Label: choecalciferol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol; Assigned to Arm(s): choecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol D3; Assigned to Arm(s): Vitamin D | Intervention Type: OTHER; Name: Placebo tablet; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy
Brief Summary: This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs.


Options:
A: Arm Label: Bupivacaine HCl; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupivacaine HCl | Arm Label: SKY0402; Type: OTHER; Interventions: Drug: SKY0402 | Intervention Type: DRUG; Name: Bupivacaine HCl; Assigned to Arm(s): Bupivacaine HCl | Intervention Type: DRUG; Name: SKY0402; Assigned to Arm(s): SKY0402
B: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL; Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL
C: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL (bupivacaine liposome injectable suspension); Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL (bupivacaine liposome injectable suspension)
D: Arm Label: Morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: morphine sulfate | Arm Label: EXPAREL; Type: EXPERIMENTAL; Interventions: Drug: bupivacaine liposome extended-release injectable suspension | Intervention Type: DRUG; Name: morphine sulfate; Assigned to Arm(s): Morphine sulfate | Intervention Type: DRUG; Name: bupivacaine liposome extended-release injectable suspension; Assigned to Arm(s): EXPAREL

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy
Brief Summary: This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.


Options:
A: Arm Label: IV Morphine Sulfate or Sponsor-approved Equivalent; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate or Sponsor-approved equivalent | Arm Label: EXPAREL; Type: EXPERIMENTAL; Interventions: Drug: EXPAREL | Intervention Type: DRUG; Name: IV morphine sulfate or Sponsor-approved equivalent; Assigned to Arm(s): IV Morphine Sulfate or Sponsor-approved Equivalent | Intervention Type: DRUG; Name: EXPAREL; Assigned to Arm(s): EXPAREL
B: Arm Label: Bupivacaine HCl; Type: ACTIVE_COMPARATOR; Interventions: Drug: SKY0402 | Arm Label: SKY0402; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupivacaine HCl | Intervention Type: DRUG; Name: SKY0402; Assigned to Arm(s): Bupivacaine HCl | Intervention Type: DRUG; Name: Bupivacaine HCl; Assigned to Arm(s): SKY0402
C: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL (bupivacaine liposome injectable suspension); Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL (bupivacaine liposome injectable suspension)
D: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL; Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy
Brief Summary: This study is designed to compare the standard of care against EXPAREL(R) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.


Options:
A: Arm Label: Bupivacaine and low dose SKY0402; Type: N/A; Interventions: Drug: Questionnaire and Physical Exam | Arm Label: Bupivacaine and high dose SKY0402; Type: N/A; Interventions: Drug: Questionnaire and Physical Exam | Arm Label: Bupivacaine; Type: N/A; Interventions: Drug: Questionnaire and Physical Exam | Arm Label: High dose SKY0402; Type: N/A; Interventions: Drug: Questionnaire and Physical Exam | Intervention Type: DRUG; Name: Questionnaire and Physical Exam; Assigned to Arm(s): Bupivacaine, Bupivacaine and high dose SKY0402, Bupivacaine and low dose SKY0402, High dose SKY0402
B: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL (bupivacaine liposome injectable suspension); Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL (bupivacaine liposome injectable suspension)
C: Arm Label: IV morphine sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV morphine sulfate | Arm Label: EXPAREL; Type: EXPERIMENTAL; Interventions: Drug: EXPAREL (bupivacaine liposome injectable suspension) | Intervention Type: DRUG; Name: IV morphine sulfate; Assigned to Arm(s): IV morphine sulfate | Intervention Type: DRUG; Name: EXPAREL (bupivacaine liposome injectable suspension); Assigned to Arm(s): EXPAREL
D: Arm Label: Group 1 Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Group 1 Standard of Care | Arm Label: Group 2 EXPAREL; Type: ACTIVE_COMPARATOR; Interventions: Drug: Group 2 EXPAREL | Intervention Type: DRUG; Name: Group 1 Standard of Care; Assigned to Arm(s): Group 1 Standard of Care | Intervention Type: DRUG; Name: Group 2 EXPAREL; Assigned to Arm(s): Group 2 EXPAREL

Answer: B